University Institute of Biochemistry and Biotechnology
Dr. Muhammad Javaid Asad
Student enrolled
Programs Offered
Ph.D faculty
Total Graduates
About Department
Introduction
The discipline of Biochemistry in PMAS-AAUR was initially introduced under the umbrella of the Department of Biological Sciences in 1998 and as a separate Department in 2003. The Department of Biochemistry was up-graded to the University Institute of Biochemistry and Biotechnology (UIBB) in 2011. The institute aims to excel in advanced research in Biochemistry, Molecular Biology and Biotechnology to provide means in controlling various diseases related to plant, animal and human as well as to enhance agriculture and livestock productivity with particular emphasis to high priority areas related to Pakistan’s economic growth.
The faculty of UIBB is highly qualified and competent with doctorate and post-doctoral experience from reputable National and International Universities/Institutes with research specialization in diverse fields like, Biochemistry, Molecular Biology, Plant Biochemistry, Plant Biotechnology, Nanotechnology, Animal Biotechnology, Industrial Biotechnology, Fermentation Technology, Enzymology, Nutritional Biochemistry, Natural Products Chemistry, Human Molecular Genetics, Clinical Biochemistry, Cancer Genetics, Epigenetics, Biofuels, Protein Chemistry, Bioinformatics, etc. All faculty members have track record of publications in impact factor journals, won research grants from various funding agencies and are HEC approved PhD supervisors. The faculty of UIBB has successfully maintained active scientific collaborations with highly reputed national and international universities and research institutes.
The degree programs offered by UIBB are designed to provide necessary skills and knowledge in applying biochemical and molecular approaches for the solution of problems related to Health, Agriculture, Industry, and Biotechnology. The curriculum for different degree programs offered is designed based on international standards with highly competitive and advanced theoretical and practical courses. The curriculum is regularly updated keeping in view the recent advances in the relevant fields. In addition, the institute also offers compulsory courses to other departments and faculties of the university. Along with regular academic activities, the institute has a rich tradition to conduct scientific conferences, workshops, symposia, and seminars to train young scientists with modern techniques in Biochemistry, Molecular Biology, and Biotechnology.
Vision
To achieve excellent standards of quality education and research by promoting culture of honesty, opportunity, diversity, and professional excellence
Mission
To excel in innovative scientific education and research.
To produce intellectual, highly committed, and diverse scientific manpower.
To engage in translational scientific research focused towards the benefit of humanity.
Faculty Members
Dr. Muhammad Javaid Asad
Director
Email: [email protected]
Dr. Abida Raza
Professor
Email: [email protected]
Dr. Muhammad Sheeraz Ahmad
Associate Professor
Email: [email protected]
Dr. Feroza Hamid Wattoo
Associate Professor
Email: [email protected]
Dr. Sadia Saeed
Associate Professor
Email: [email protected]
Dr. Pakeeza Arzoo Shaiq
Assistant Professor
Email: [email protected]
Dr. Tayyaba Zainab
Assistant Professor
Email: [email protected]
Dr. Bilal Muhammad Khan
Assistant Professor
Email: [email protected]
Dr. Uzma Abdullah
Assistant Professor
Email: [email protected]
Ms. Hina Ali
Lecturer
Email: [email protected]
Ms. Saima Amin
Lecturer
Degree Programs
BS (Biochemistry)
F.Sc (Pre-Medical) with at least 45% marks. Seats are on all Pakistan basis. Must have passed University Entrance Test.
BS (Medical Lab Technology)
F.Sc (Pre-Medical) with at least 50% marks. F.Sc (MLT) with at least 50% marks. Seats are on all Pakistan basis. Must have passed University Entrance Test.
BS - 2 Year (5th Semester)
Eligibility
B.Sc (14 years of education)/ADP or equivalent degree in the relevant subject with at least 45% marks. Seats are on all Pakistan basis. Must passed university entrance test
BS (Microbiology)
F.Sc (Pre-Medical) with at least 45% marks. Seats are on all Pakistan basis. Must have passed University Entrance Test.
BS (Clinical Psychology)
F.Sc (Pre-Medical) or Equivalent with at least 50% marks. Seats are on all Pakistan basis. Must have passed University Entrance Test.
M.Phil (Biochemistry/Biotechnology)
For. M.Phil Biochemistry a candidate must have passed BS/M.Sc in Biochemistry/Molecular Biology with CGPA of at least 2.50/4.00. For. M.Phil Biotechnology a candidate must have passed BS/M.Sc in Biotechnology, Biochemistry/Molecular Biology, Biology, Bioinformatics, Microbiology, Botany, Zoology with CGPA of at least 2.50/4.00. Must have passed University Entrance
BS (Biotechnology)
F.Sc (Pre-Medical) with at least 45% marks. Seats are on all Pakistan basis. Must have passed University Entrance Test.
BS (Aesthetics & Cosmetology)
F.Sc (Pre-Medical) with at least 50% marks. Seats are on all Pakistan basis. Must have passed University Entrance Test.
Ph.D (Biochemistry/Biotechnology)
MS/MPhil with first division in relevant filed or CGPA of at least 3.00/4.00. Must have passed University GRE Type Subject Test with 70% Marks. The PhD applications must be accompanied by comprehensive research proposals along with consent letter from concerned supervisor with justification of resources.
Research
Research Divisions
There are six main and broad research domains in the University Institute of Biochemistry and Biotechnology:
| S# | Research Divisions | Research Division Head |
| 1 | Animal Biochemistry and Biotechnology | Prof. Dr. Ghazala Kaukab Raja |
| 2 | Enzymology and Industrial Biotechnology | Dr. Muhammad Javaid Asad |
| 3 | Plant Biochemistry and Biotechnology | Dr. Muhammad Sheeraz Ahmad |
| 4 | General Biochemistry/Biotechnology | Dr. Feroza Hamid Wattoo |
| 5 | Microbiology | Director UIBB |
| 6 | Bioinformatics | Director UIBB |
News & Events
News & Events
- Tobacco Awareness Seminar (15 Nov, 2024)
- Road Safety Awareness & Bike Licence (14 Nov, 2024)
- Stay Safe on Roads (14 Nov, 2024)
- 2nd Hands-on Training on The Kjeldahl Experience (13 Nov, 2024)
- Internation Symposium on Research Techniques (30 Oct, 2024)
- Bridging Biosafety and Biosecurity Gaps (24 Sep, 2024)
- Thalassemia Awareness Seminar (07 Mar, 2024)
- Rare Genetic Disorders in Human (28 Feb, 2024)
- Cardiovascular Diseases in Asian Women (22 Feb, 2024)
Translational Genomics Lab
Genetic Database
Catalogue Generation of DMD Mutation Database
Collated Data of DMD Mutations Reported in Pakistani Patients
| Sr.# | Year of Publication | No. of Cases Reported | Total % Age Of Deletions | Deletion % Age in Proximal Region | Deletion % Age in Distal Region | Total % Age Of Duplications | Technique Used for Identification | Disease Severity | References/ DOI’s |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1994 | 2 | – | – | – | – | Muscle Biopsy Based study | Mild | (Sewry, Sansome, Matsumura, Campbell, & Dubowitz, 1994) https://doi.org/10.1016/0960-8966(94)90003-5 |
| 2 | 2011 | 6 fam | – | – | – | – | PCR, SCK analysis | Mild | (Hashim, Shaheen, Ahmad, Sattar, & Khan, 2011) https://pubmed.ncbi.nlm.nih.gov/22830166/ |
| 3 | 2008 | 211 | 86 cases (40.75%) | 5 patients (40.69%) | 51 patients (59.30%) | Not commented | PCR with 18 primer pairs | Severe | (Hassan et al., 2008) https://doi.org/10.1111/j.1442200X.2008.02538.x |
| 4 | 2017 | 9 | 8 (90%) F (20 %) M (70%) |
More proximal | Less distal | Not commented | MPCR with 16 sets of primers | Severe | (Rahim, 2017) http://www.iraj.in/journal/journal_file/journal_pd f/6-406-151141926749-55.pdf |
| 5 | 2018 | 1 | het del in exons 49-50 | Not commented | Not commented | Not commented | MLPA | Mild (Becker MD) | (Asghar Nasir, Munim, Imam, & Hasan) https://ideas.repec.org/a/abf/journl/v12y2018i3p1 -3.html |
| 6 | 2018 | 68 (3% Pakistani) | 66.2% | Not commented | Not commented | 4.4% | Multiplex PCR/MLPA | Severe | (Mohammed et al., 2018) https://journals.plos.org/plosone/article?id=10.13 71/journal.pone.0197205 |
| 7 | 2019 | 46 44 (M) 2 (F) |
40 | exons 45 and 52 | exons 8 and 18 | 6 cases exons 3 and 7 | MLPA | Mild | (Ansar et al., 2019) https://doi.org/10.1089/gtmb.2018.0262 |
| 8 | 2019 | 92 85 (M) & 7 (F) |
38 cases (45%) | M= 44 (52%) 2/7 F (30%) |
Not commented | 6 cases (7%) | MLPA | Mild | (Ahmed, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC 6752354/ |
| 9 | 2021 | 3 | 4 missense variants | 1 nonsense variant | Not commented | Not commented | WES, Sanger sequencing | Severe | (Zehravi, Wahid, Ashraf, & Fatima, 2021) https://doi.org/10.1089/gtmb.2020.0246 |
| 10 | 2021 | 2 | no deletions | Not commented | Not commented | Not commented | PCR, Sequencing | Mild | (Khan et al., 2021) https://readersinsight.net/PJMLS/article/view/212 0 |
| 11 | 2023 | 60 | 32 cases (56%) Exons 45-52 | Not commented | (43%) | 10 cases (17.5%) Exon 3-7 | MLPA | Severe | (Rafique et al., 2023) https://doi.org/10.56310/pjns.v18i01.231 |





